Chicago — June 2, 2015 — L.E.K. Consulting, a global management consulting firm, today announced that Ken Graves has joined the firm’s Americas practice and will be based out of Chicago. Graves brings more than 18 years of strategy consulting experience that spans the U.S. and Asia. He previously served as the representative director of L.E.K.’s Japan practice. He will continue to focus on advising global clients in the MedTech and Biopharma & Life Sciences sectors.


“We are very excited to welcome Ken to our Chicago office as he will be an important partner in helping to expand our BioPharma & Life Sciences and MedTech practices,” said Peter McKelvey, managing director and president of the Americas practice. “His experience helping multinational companies on corporate and market growth strategies, as well as his world view on a broad range of issues in MedTech and Biopharma, will add tremendous value to our clients.”

Graves’ expertise extends to market growth strategy, business model development and alignment, market access strategy and commercial launch support, among others. He has been advising global firms on their critical strategic issues with L.E.K. since 2007.

“I look forward to continuing to advise L.E.K.’s global clients from my new base in Chicago, as we help them drive their business to the next level,” said Graves.

About L.E.K. Consulting
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and analytical rigor to help clients solve their most critical business problems. Founded more than 30 years ago, L.E.K. employs more than 1,000 professionals in 21 offices across the Americas, Asia-Pacific and Europe. L.E.K. advises and supports global companies that are leaders in their industries – including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. L.E.K. helps business leaders consistently make better decisions, deliver improved business performance and create greater shareholder returns. For more information, go to

Emmy Llewellyn